AllDocs -> cancers

Testis Cancer survival, incidence and mortality in NSW 1994–2000 48 The Cancer Council NSW Testis cancer • The five-year relative survival from testis cancer in NSW between 1994 and 2000 was 95.6% • There was no area variation in the adjusted relative risks of excess death due to testis cancer after shrinking • There were 935 new cases of testis cancer in NSW in 1994 to 1998 and 53 deaths • There were no Area Health Services in which the number of deaths from testis cancer was different from expected, and there was no area variation in the excess number of new cases of testis cancer Table 22a: Five-year relative survival, relative risk of excess deaths due to cancer and excess cancer deaths after shrinking with 95% confidence intervals and potential lives savable by Area Health Services in NSW 1994 – ...

HEALTH Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board Budget & Control Board STATE HEALTH PLAN PREVENTION PARTNERS South Carolina Budget and Control Board Employee Insurance Program April 2003 What is Testicular Cancer ? Testicular ...

ELECTRONIC LETTER Y chromosome haplotypes and testicular cancer in the English population L Quintana-Murci, M E Weale, M G Thomas, E Erdei, N Bradman, J H Shanks, C Krausz, K McElreavey . J Med Genet 2003;40:e20(http://www.jmedgenet.com/cgi/content/full/40/3/e20) T esticular cancer (TC) affects 1 in 500 males and is the most common malignancy among young men in western Euro- pean populations; for example, in Denmark 1% of all men now develop TC. 1–4 More than 97% of testes cancers are germ cell tumours. 4 Although the aetiology of these malignancies is unknown, there is accumulating evidence of an intrauterine stage of TC development that may involve both environmental and genetic factors acting on the primordial gonocyte. 4 Although many tumour suppressor genes have been studied, there is little evidence supporting ...

CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e • N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Testicular Cancer : Questions and Answers Key Points • Testicular cancer can be one of two general types: seminoma or nonseminoma (see Question 1). • This disease occurs most often in men between the ages of 15 and 39. It accounts for only 1 percent of all cancers in men (see Question 1). • Risk factors include having an undescended testicle, a previous testicular cancer , or having a brother or father who has had testicular cancer (see Question 2). • Symptoms include a lump, swelling, or enlargement in the testicle; an ache in the lower abdomen, back, or groin; and pain or discomfort in a testicle or in the scrotum ...

Section 1 Genitourinar y: Testicular Cancer 55 Neutropenic Infection 5% Nausea/Vomiting 70% Neurologic 7% Respiratory 5 % Hepatic 3% Pulm. Hemorrhage <1% Resp. Failure 1% Neutropenic Nadir Sepsis 10% Nausea/Vomiting* 44% Stomatitis 2% Alopecia † ~100% *Grade I–II toxicity † Unknown grade of toxicity Neutropenic Sepsis 4% Thrombocytopenia 5% Paresthesias* 38% Abdominal Pain* 20% Myalgias* 19% *Unknown grade Neutropenic Infection 6% Nausea/Vomiting 9% Neurological 8% Respiratory 40% Hepatic 3% Renal 5% Days 1–5— level 5 Days 9, 16— level 1 Day 1–5— level 5 Days 1–5— level 4 Days 9, 16— level 1 Days 1–5— level 5 Days 1–5— level 5 Toxic mortality 4% Pulmonary toxicity leading to ...

Essay Testicular cancer is most commonly found in adolescents or young adults. To any young man in my situation, I would highly recommend the book, It's Not About the Bike My Journey Back to Life by Lance Armstrong. One of the keys to physical, mental, and emotional survival during cancer treatment is maintaining a positive outlook. A cancer patient needs a positive attitude and a persistent hope that health will be restored and the cancer will be defeated. In this way, Lance Armstrong's story is an excellent motivator. Lance not only had cancer in the testicle but it had spread throughout his body. He had surgery and chemotherapy. His was just about the worst possible scenario with the best possible outcome. Reading his story gives a cancer patient hope that he, too, can overcome the many obstacles of cancer , no matter how bad things look at the beginning. Lance is ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com * Findings were statistically significant (strong evidence) + Evidence of a dose-response relationship (strongest evidence) Page 96 Testicular Cancer and Exposure to Ionizing Radiation Summary: Evidence varies on whether there may be an connection between testicular cancer and exposure to ionizing radiation. This connection is supported by some evidence from studies of nuclear workers in England who have been exposed to ionizing radiation. The National Research Council’s, on the other hand, has determined that the testis are relatively insensitive to ionizing radiation. Testicular cancer is not designated as a “specified” cancer under the Energy Employees Occupational Illness Compensation Program ...

A Case-Control Study of Dietary Phytoestrogens and Testicular Cancer Risk Farzana L. Walcott, Michael Hauptmann, Cherie M. Duphorne, Patricia C. Pillow, Sara S. Strom, and Alice J. Sigurdson Abstract: A few dietary studies have found elevated testicular cancer risks for higher red meat, fat, and milk in- takes and lower intakes of fruits, vegetables, and fiber. Be- cause hormonal modulation by dietary intake of plant estrogens could affect risk of testicular cancer , we chose to explore the possible relationship between dietary phytoes- trogens and testicular cancer . We conducted a hospital- based case-control study of 159 testicular cancer cases di- agnosed between 1990 and 1996 and 136 adult friend- matched controls at the University of Texas M. D. Anderson Cancer Center. Amounts of phytoestrogenic compounds in foods ...

533 Second Malignancies After Testicular Cancer To the Editor: Testicular cancer has become the paradigm of a curable malignancy, with a 5-year relative survival rate of greater than 90%. 1 This markedly improved outlook underscores the need for quantitative data on the late complications of therapy, especially second malignancies. However. given the rarity of testicular cancer , 1 most surveys contain only small numbers of patients, as reviewed recently by Dieckmann et al, 2 precluding estimation of site-specific risks. To clarify these risks, we have quantified the occurrence of second malignancies among more than 9,700 men with testicular cancer , using resources of the National Cancer Institute’s Surveil- lance, Epidemiology, and End Results Program (1973 to 1991) and the earlier years of the Connecticut Tumor Registry ...

_ The contents above are supplied for information only and should not be relied upon as medical advice. If medical advice or other expert assistance is required, the services of a qualified medical professional should be sought. © Copyright 2001, Andrology Australia Last Updated: October 2001 Page 1 Causes of Testicular Cancer Author: A/Professor Mark Frydenberg Monash Medical Centre, Clayton, Australia What is Cancer ? Cancer describes a range of diseases that affect the cells that make up the tissues and organs in the body. Cells normally grow and divide in a controlled way, but sometimes, this process gets out of control and the cells continue to divide to form an abnormal growth or lump called a tumour. Tumours can be benign or malignant . A benign tumour is not cancerous as the abnormal cells do not invade other tissues or spread ...

The contents above are supplied for information only and should not be relied upon as medical advice. If medical advice or other expert assistance is required, the services of a qualified medical professional should be sought. © Copyright 2001, Andrology Australia Last Updated: October 2001 Page 1 Treatment of Testicular Cancer Author: A/Professor Mark Frydenberg Monash Medical Centre, Clayton Australia Treatment options A referral to a specialist doctor (Urologist) for the treatment of testicular cancer is most likely. The type of treatment is based on the results of tests, the stage of the disease and whether the cancer has spread to other parts of the body. There are three main types of treatment that may be used either on their own or together to treat testicular cancer . Surgery Radiotherapy Chemotherapy A solid lump ...

Screening for Testicular Cancer C H A P T E R 74 By R. Wayne Elford Page 2 Screening for Testicular Cancer 74 Adapted to the Canadian context by R. Wayne Elford, MD, CCFP, FCFP, 1 from the report prepared for the U.S. Preventive Services Task Force 2 I n 1 984, the Canadian Task Force on the Periodic Health Examination recommended that screening should be performed only on patients with a history of cryptorchidism, testicular atrophy or ambiguous genitalia.< 1 > In our current review we find insufficient evidence to include or exclude routine screening for testicular cancer in the general population (C Recommendation). Burden of Suffering Testicular cancer is a relatively ...

For Internal Use Only. Not For Use With The Public. This material is intended for insurance informational purposes only and is not personal medical advice for clients. Testicular Cancer Although overall it is uncommon, testicular cancer is the most common type of cancer in young men age (15-35). The incidence of testicular cancer has been increasing, but mortality rates are improving due to dramatic advances in its treatment. The usual presentation of this cancer is a painless mass. Risk Factors ? Cryptorchidism (undescended testicle) ? Previous testicular cancer in opposite testis ? History of mumps orchitis, inguinal hernia, or hydrocele in childhood ? High socioeconomic status Germ cell cancers account for 95% of testicular cancer and can be subdivided in to seminomas and nonseminomas. Non-germ cell cancers account for the other ...

T his book is designed to provide the urologic oncologist with informa- tion on the epidemiology of testic- ular and penile cancer and on the diag- nostic and therapeutic approach to patients with this disease. As such, the content is appropriate not only for urolog- ic oncologists but also for those in train- ing. The editors have assembled a nation- al, multidisciplinary group of authors who are recognized experts in the field. The book is organized into two parts. The first part consists of 11 chapters that address the epidemiology, pathology, and molecular biology of testicular cancer ; diagnostic and therapeutic approaches reviewed include surgery, radiation therapy, and chemo- therapy. In this section, fertility is discussed, as is the man- agement of extragonadal germ cell tumors. By nature of the rarity of penile cancer in North America, the discussion ...

1 TESTICULAR CANCER Neil Fleshner MD MPH FRCSC Associate Professor of Surgery University of Toronto Head, Division of Urology University Health Network Head, Genitourinary Cancer Program Princess Margaret Hospital Head of Research, Department of Surgical Oncology, University Health Network TESTICULAR CANCERS • Most common solid tumours among men 18-40 • Vast majority: Germ Cell Tumours • Cell of origin: seminferous tubular epithelium • Risk Factor: cryptorchidism(~18 fold) – Both sides at higher risk Page 2 2 GERM CELL TUMOURS: HISTOLOGY • SEMINOMA (~50%) – Anaplastic – Spermatocytic – Classic • NON-SEMINOMA (NSGCT) (~50%) – Embryonal – Choriocarcinoma – Yolk Sac – Teratoma Page 3 3 ...

166 N ORTH ERN C ALIFORNIA C ANCER C ENTER , Cancer Incidence and Mortality in the Greater San Francisco Bay Area Testicular Cancer • For the period 1988 through 2000, incidence rates for testicular cancer remained stable (Table 1). • Between 1996 and 2000, testicular cancer incidence rates were highest in whites and lowest in blacks (Table 1). • Testicular cancer , a disease predominantly affecting young adult men, was most likely to occur between the ages of 20 and 40 and was rare after age 69 (Table 2). • There was no substantial difference in testicular cancer occurrence by county (Table 3). TABLE 1. Testicular Cancer . Annual Case Counts, Age-Adjusted Incidence Rates per 100,000 Males, a and 95% Confidence Intervals (CI), ...

308 N ORTHERN C ALIFORNIA C ANCER C ENTER , Cancer Incidence and Mortality in the Greater San Francisco Bay Area Testicular Cancer TABLE 1. Testicular Cancer . Annual Death Counts, Age-Adjusted Mortality Rates per 100,000 Males, a and 95% Confidence Intervals (CI), by Race/Ethnicity, 1988- 2000, Greater San Francisco Bay Area b MALES Year Count Rate 95% CI ALL RACES 1988-1993 c 55 0.3 0.2-0.4 1994 10 0.3 0.1-0.7 1995 7 0.2 0.1-0.5 1996 11 0.4 0.2-0.7 1997 9 0.3 0.1-0.6 1998 10 0.3 0.2-0.7 1999 7 0.2 0.1-0.5 2000 5 0.1 0.0-0.4 1996-2000 ...

Request for Applications Illinois Prostate and Testicular Cancer Education and Awareness Program July 1, 2002 – June 30, 2003 Illinois Department of Public Health Office of Health Promotion Division of Chronic Disease Prevention and Control Men’s Health Program 535 West Jefferson, 2 nd Floor Springfield, Illinois 62761 Phone: 217-782-3300 Fax: 217-782-1235 Page 2 Illinois Prostate and Testicular Cancer Page 2 Education and Awareness Program Illinois Department of Public Health Office of Health Promotion Illinois Prostate and Testicular Cancer Education and Awareness Program April 1, 2002 Request for Application for State Fiscal Year 2003 Application Package Contents: • Background and Purpose • General Information • Instructions ...

Copyright © 1998 by W.B. Saunders Company. All rights reserved. 478 A BASIC INFORMATION DESCRIPTION Uncontrolled growth of malignant cells in the testicle. There are several types of testicular cancer , some more dangerous than others. This is the most common form of cancer in young men. Affects all ages, but more often is found in men ages 20-40. FREQUENT SIGNS AND SYMPTOMS • A firm swelling in one testicle discovered by accident or by self-examination. • No pain (90% of cases). • Sense of fullness in the scrotum. CAUSES Unknown. RISK INCREASES WITH • Undescended testicle(s) in infancy even if the testicle was surgically moved into the scrotum. • Caucasian race. • Estrogen administration to the mother during preg- nancy. PREVENTIVE MEASURES Males should examine testicles routinely at least once a month. Will ...

National Cancer Institute National Institutes of Health NIH Publication No. 02-5189 August 2002 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health Familial Testicular Cancer Clinical Genetics Branch* Division of Cancer Epidemiology and Genetics ABOUT THE RESEARCH TEAM Mark H. Greene, M.D. , is the lead investigator for the study and Chief of the NCI Clinical Genetics Branch. He has been caring for and studying patients with familial and hereditary cancers for 25 years. W. Marston Linehan, M.D., Ph.D. , is the Chief of the NCI Urologic Oncology Branch. He is one of the world’s leading authorities on hereditary cancers arising in the genitourinary system. Joan L. Kramer, M.D. , is board certified in internal ...

Current Status of Retroperitoneal Lymph Node Dissection and Testicular Cancer : When to Operate Richard Foster, MD, and Richard Bihrle, MD Background: Historically, retroperitoneal lymph node dissection (RPLND) has been used in the therapy of both low-stage and high-stage testicular cancer after chemotherapy. As other therapies have developed, the role of RPLND has also evolved. Methods: The authors review the current indications for RPLND in the therapy of testicular cancer . Results: Metastatic testicular cancer can be cured in 50% to 75% of cases by surgical removal using RPLND, depending on the volume of metastasis. In postchemotherapy disease, the surgical removal of teratoma or carcinoma also confers a therapeutic benefit to the patient. Conclusions: The therapeutic capability of RPLND in low-stage testicular cancer is underappreciated. In ...

For Internal Use Only. Not For Use With The Public. This material is intended for insurance informational purposes only and is not personal medical advice for clients. Prudential Financial is a service mark of The Prudential Insurance Company of America, Newark, NJ and its affiliates The Prudential Insurance Company of America 751 Broad Street, Newark, NJ 07102-3777 RX36 DOC IFS-A005663, Ed. 05/02, Exp. 11/03 Testicular Cancer Although overall it is uncommon, testicular cancer is the most common type of cancer in young men age (15-35). The incidence of testicular cancer has been increasing, but mortality rates are improving due to dramatic advances in its treatment. The usual presentation of this cancer is a painless mass. Risk Factors ? Cryptorchidism (undescended testicle) ? Previous testicular cancer in opposite testis ? History of mumps ...

Prudential Financial is a service mark of The Prudential Insurance Company of America, Newark, NJ and its affiliates The Prudential Insurance Company of America 751 Broad Street, Newark, NJ 07102-3777 RX36 DOC IFS-A005663, Ed. 04/02, Exp. 10/11/03 83 Testicular Cancer Although overall it is uncommon, testicular cancer is the most common type of cancer in young men age (15-35). The incidence of testicular cancer has been increasing, but mortality rates are improving due to dramatic advances in its treatment. The usual presentation of this cancer is a painless mass. Risk Factors ? Cryptorchidism (undescended testicle) ? Previous testicular cancer in opposite testis ? History of mumps orchitis, inguinal hernia, or hydrocele in childhood ? High socioeconomic status Germ cell cancers account for 95% of testicular cancer ...

Testicular Cancer Stage III Stage II Stage I T1- Tumor limited to the testis and epidymis without lymphatic/vascular invasion T2- Tumor limited to testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis T3- Tumor invades the spermatic cord with or without vascular/lymphatic invatsion T4- Tumor invades the scrotum with or without vascular/lymphatic invasion N0- No lymph node metastasis N1- Metastasis in a single lymph node 2cm or less in greatest dimension N2- Metastasis in a single lymph node 2-5 cm in greatest dimension; or multiple lymph nodes , none >5cm in greatest dimension N3- Metastasis in a lymph node >5cm in dimension M0- No distant metastasis M1- Distant metastasis M1a- Nonregional nodal or pulmonary metastasis M1b- Distant metastasis other than to nonregional nodes and ...

The Orchid Cancer Appeal Team Patron: Steve Davis MBE President: Michael Parkinson Vice Presidents: Pat Cash, Jason Cundy, Sir Geoff Hurst MBE, Martin Peters MBE, Geoff Thompson MBE and Ronnie Whelan. Trustees: Colin Osborne CHAIRMAN , Judge Graham Boal QC, Professor Tim Oliver MD FRCP and Dr Mary Quigley FRCP FRCR Centres In The Anglian Cancer Research Group Supported By The Orchid Cancer Appeal Leaflets Sponsored by Charterhouse Printing Ltd. London Designed by The Orchid Cancer Appeal © The Orchid Cancer Appeal 1997 IPSWICH NORWICH COLCHESTER CAMBRIDGE SOUTHEND OLDCHURCH ROYAL HOSPITALS TRUST TESTICULAR CANCER AWARENESS LEAFLET The Orchid Cancer Appeal Formed in June 1996 by former testis cancer ...

CFC Number 0481 Testicular Cancer Early Detection is Key THE FACTS Testicular cancer can occur in males of all ages, including infants and elderly men. However it is most common in men 15 to 40 years old. The testicles are two organs contained in a sac of skin called the scrotum, which hangs beneath the base of the penis. The testicles produce and store sperm and are the main source of male hormones. In the year 2002, approximately 7,500 males will be diagnosed with testicular cancer and 400 males will die from the disease. When found early, testicular cancer is one of the most treatable forms of cancer , with an overall cure rate above 90 percent. Testicular cancer incidence has more than doubled among white Americans in the past four decades, while remaining the same for African-Americans. ...

Testicular Cancer Basic Description Testicular cancer can develop in one or both testicles in men and boys. Contained in a sac of skin called the scrotum, the testicles are the part of the male reproductive system that produce sperm and male hormones (like testosterone). The testicles contain several types of cells, each of which may develop into one or more types of cancer . The following are symptoms of testicular cancer : • Lump in either testicle • Any enlargement of a testicle • Feeling of heaviness in the scrotum • Dull ache in the lower abdomen or the groin • Sudden collection of fluid in the scrotum • Enlargement or tenderness of the breasts Opportunities Prevention The main risk factors for testicular cancer are having an undescended testicle at ...

Review Articles Medical Progress 242 Ju l y 2 4 , 1 9 9 7 T h e New E n g l a n d Jo u r n a l o f Me d i c i n e T ESTICULAR G ERM -C ELL C ANCER G EORGE J. B OSL , M.D., AND R OBERT J. M OTZER , M.D. From the Genitourinary Oncology Service, Division of Solid Tumor On- cology, Department of Medicine, Memorial Sloan-Kettering Cancer Cen- ter, and the Department of Medicine, Cornell University Medical College, New York. Address reprint requests to Dr. Bosl at Memorial Hospital, 1275 York Ave., New York, NY 10021. ©1997, Massachusetts Medical Society. PPROXIMATELY 95 percent of malignant tumors arising in the testis are germ-cell tu- mors, a term that indicates their origin in primordial germ cells. ...